MSGS | Ticker Profile - Titan Protect

MSGS

Madison Square Garden Sports Corp.

Communication Services · Entertainment · NYQ

$386.23

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

MODERATE

Data Confidence: 71.4%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$8.8B

Total market value of the company

Trailing P/E

N/A

Forward P/E

-1,023.04

Based on estimated future earnings — lower means cheaper

Rev Growth

+1.9%

Year-over-year revenue change

Profit Margin

-2.1%

How much profit the company keeps from each dollar of revenue

ROE

N/A

Return on equity — how efficiently it uses shareholder money

Analyst Target

$402.00

+4% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 6 analysts covering this stock

About Madison Square Garden Sports Corp.

Madison Square Garden Sports Corp. operates as a professional sports company in the United States. The company owns and operates a portfolio of assets that consists of the New York Knickerbockers of the National Basketball Association (NBA) and the New York Rangers of the National Hockey League. Its other professional franchises include development league teams, the Hartford Wolf Pack of the American Hockey League and the Westchester Knicks of the NBA G League. It also operates the Madison Square Garden Training Center, a professional sports team performance center in Greenburgh. The company was formerly known as The Madison Square Garden Company. Madison Square Garden Sports Corp. was incorporated in 2015 and is based in New York, New York.

https://www.msgsports.com

Country: United States Employees: 514 Industry: Entertainment

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

1.498

Excellent risk-adjusted returns

Kelly Fraction

0.1352

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

1.662

Returns exceed worst-case losses — strong risk profile

Annual Return

42.5%

Historical annualised return based on price data

Max Drawdown

-25.5%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.57

Less volatile than the market — more defensive

52W High

$370.00

-4% below the year high

52W Low

$186.00

108% above the year low

Avg Volume

233,027

Average daily shares traded — higher means easier to buy and sell

Short Ratio

5.0

Days it would take all short sellers to cover — higher means more crowded

Short % Float

6.3%

Moderate short interest

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-0.92

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

N/A

Current Ratio

0.46

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.37

Like current ratio but excludes inventory — stricter test

Gross Margin

29.4%

Revenue left after cost of goods — higher means pricing power

Operating Margin

0.7%

Profit from core operations before interest and tax

Free Cash Flow

$50M

Positive — the business generates more cash than it spends

Revenue (TTM)

$1.1B

Total revenue over the last 12 months

Net Income

$-22,342,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$435.00

Target Median

$402.00

Target Low

$295.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go